AMPH — Amphastar Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.12bn
- $1.45bn
- $719.89m
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray
Brief: FDA Broadens Access To Over-The-Counter Naloxone Nasal Spray For Opioid Overdose
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing
U.S. RESEARCH ROUNDUP-Cars.Com, Dell, Zscaler
Amphastar Q4 revenue misses estimates
Brief: Amphastar Pharmaceuticals Q4 EPS USD 0.51
Brief: Amphastar Announces FDA Approval for Teriparatide Injection
Amphastar Pharmaceuticals Q3 revenue beats estimates
Brief: Amphastar Pharmaceuticals Q3 EPS USD 0.37
Brief: Amphastar Pharmaceuticals Enters Contract Research Agreement With Hanxin -SEC Filing
Brief: Amphastar Pharmaceuticals Enteres License Agreement With Nanjing Anji Biotechnology
Amphastar Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary